ACUTE PYELONEPHRITIS
Clinical trials for ACUTE PYELONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE PYELONEPHRITIS trials appear
Sign up with your email to follow new studies for ACUTE PYELONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapons against superbugs: trial tests promising antibiotic combos
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for serious, drug-resistant bacterial infections. It involved 126 hospitalized adults with infections like pneumonia, urinary tract infections, o…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New antibiotic duos battle Drug-Resistant kidney infections
Disease control CompletedThis large, completed Phase 3 study tested whether two new combinations of antibiotics (cefepime/nacubactam and aztreonam/nacubactam) work as well as a standard antibiotic (imipenem/cilastatin) for treating serious urinary tract or kidney infections in adults. The main goal was t…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New antibiotic combo battles tough kidney infections in hospital trial
Disease control CompletedThis study tested whether a new antibiotic combination (cefepime-zidebactam) works as well as a standard antibiotic (meropenem) for treating serious urinary tract or kidney infections that require hospitalization. About 530 adults with these infections received one of the two tre…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Pill could replace IV drips for serious infections
Disease control CompletedThis large, completed Phase 3 study compared a new oral antibiotic pill to a standard intravenous (IV) antibiotic for hospitalized adults with serious kidney or urinary tract infections. The goal was to see if the pill worked just as well to cure the infection and clear the bacte…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC